Progress in voluntary medical male circumcision for HIV prevention supported by the US President's Emergency Plan for AIDS Relief through 2017: longitudinal and recent cross-sectional programme data.
Stephanie Marie DavisJonas Z HinesMelissa HabelJonathan M GrundRenee RidzonBrittney BaackJonathan DavitteAnne ThomasValerian KiggunduNaomi BockParan PordellCaroline CooneyIrum ZaidiCarlos ToledoPublished in: BMJ open (2018)
Over 15 million VMMCs have been supported by PEPFAR since 2007. VMMC continues to attract primarily young clients. The non-trivial proportion of clients not testing for HIV is expected, and may be reassuring that testing is not being presented as mandatory for access to circumcision, or in some cases reflect test kit stockouts or recent testing elsewhere. While VMMC is extremely safe, achieving the highest possible follow-up rates for early diagnosis and intervention on complications is crucial, and programmes continue to work to raise follow-up rates. The VMMC programme has achieved rapid scale-up but continues to face challenges, and new approaches may be needed to achieve the new Joint United Nations Programme on HIV/AIDS goal of 27 million additional circumcisions through 2020.
Keyphrases
- hiv aids
- antiretroviral therapy
- cross sectional
- hiv testing
- hiv infected
- study protocol
- human immunodeficiency virus
- hiv positive
- healthcare
- randomized controlled trial
- men who have sex with men
- public health
- emergency department
- hepatitis c virus
- electronic health record
- risk factors
- machine learning
- big data
- clinical trial
- middle aged
- artificial intelligence
- south africa
- deep learning